Mean reduction in glycemic parameters at Week @ ( HbA@c : -@ % vs -@ % , p = @ ; FBG : -@ mmol/L vs -@ mmol/L , p = @ ; PPG : -@ mmol/L vs -@ mmol/L , p = @ ) and Week @ ( HbA@c : -@ % vs -@ % , p = @ ; FBG : -@ mmol/L vs -@ mmol/L , p = @ ; PPG : -@ mmol/L vs -@ mmol/L , p = @ ) was not significantly different between the hydroxychloroquine and pioglitazone groups .